Cytodyn Inc (CYDY)

[vivamiga]

Such a distortion of facts.
I have looked at the exclusion criteria for the trial. You suggest with your picture that this is a wide range of critical patients. In fact, the criteria exclude only a small proportion of critical patients (e.g. pregnancy). And I have heard very little about pregnant women who have gone critical. In general, they are young. The other exclusion criteria don't seem relevant either. Of course, you want to exclude patients from the trial if there is a risk that they will die the very next day anyway, when the effect of LL doesn't kick in until day 3.
You're assuming a mortality across the range of critical patients of 35%. This may perhaps be the average. The mortality may go up to 80% in the critical patients, depending on which part of the critical patients was included in the trial. I assume that these were only the most critical patients. This is also consistent with the facts we know. SOC got better even though as many patients died in the first 50% as died in the second 50%. This suggests that only a certain cohort of patients was treated where SOC did not improve. CYDY also had an influence on the trial and knows that it is better if only critical patients are enrolled. Therefore, many new trial hospitals were recruited at the end and an expert from CYDY visited the hospitals to advertise. The doctors have certainly not been blind to the condition of the patients and wanted to save the most critical cases first.